Neurescue
@neurescue.com
Neurescue develops medical devices to improve outcomes for emergency patients. Their flagship product, the NEURESCUE device, is the first approved for the treatment of non-shockable cardiac arrest. The device's fluoroscopy-free balloon procedure supercharges blood flow to the heart & brain, which can directly achieve a regained heartbeat or conversion to a shockable rhythm, either of which can bridge the patient to recovery. Every year, 81% of cardiac arrest patients present as non-shockable, making them ineligible for defibrillation. Today, only 4% of these patients survive. The NEURESCUE device directly addresses this urgent unmet need. The NEURESCUE device consists of a catheter and a handheld control unit. By temporarily inflating a soft balloon in the descending aorta, it redirects blood flow toward the heart and brain, supercharging circulation to the most critical organs during CPR. The intelligent, fluoroscopy-free device boosts central blood flow within one minute of deployment, which can directly restore the patient’s heartbeat in itself and buy time to bridge the patient to interventions such as a heart-lung machine and percutaneous coronary intervention. The device features automated inflation and sensor-guided feedback to facilitate a precise and safe procedure from start to finish. About Non-shockable Cardiac Arrest Non-shockable cardiac arrest cannot be treated with defibrillators. To survive a cardiac arrest, a patient must maintain blood flow to both the heart and brain and achieve a regained heartbeat or conversion to a shockable rhythm, either of which could bridge the patient to recovery.
Neurescue's Company Logos
Neurescue's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#AD6121
Desert
173, 97, 33
27, 68, 40
0, 44, 81, 32
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About Neurescue
Neurescue | Copenhagen is a pioneering brand that specializes in life-saving medical devices. Their flagship product, the Neurescue device, is the world's first intelligent fluoroscopy-free balloon catheter designed to redirect blood flow to the brain and heart for cardiac arrest patients. With its patented technology, the Neurescue device enables safe occlusion without the need for fluoroscopy, offering an innovative solution with automated filling and computer feedback to prevent mis-positioning.
This single-use kit opens up new possibilities for clinical pathways, allowing for immediate resuscitation and bridging more patients to definitive treatments such as ECMO, stents, and pacemakers. It is suitable for use in various medical settings, including bedside, intensive care, emergency rooms, and even out-of-hospital situations. The Neurescue device offers a breakthrough in intelligent and fluoroscopy-free balloon catheter technology.
It provides a safe aortic balloon occlusion, redirecting blood flow to the brain and heart for cardiac arrest patients. By increasing the immediate chance of resuscitation and bridging patients to definitive treatments intra-arrest, it aims to significantly improve survival rates and neurological outcomes. Highlighted features of the Neurescue device include automated inflation and deflation, ensuring a secure and soft occlusion throughout the procedure.
Its pressure safety design protects against over-inflation and rupture, ensuring utmost safety for patients. Additionally, this portable device is specifically designed for emergency use, with a minimal number of user steps required for successful occlusion. Neurescue | Copenhagen is committed to saving hearts and minds, and their innovative products have been funded by the European Union's Horizon 2020 research and innovation program.
For more information or inquiries, you can connect with Neurescue | Copenhagen through their website or social media platforms
Company type
Privately Held
Year founded
2014
Company size
11-50 employees
